Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) has received an average recommendation of “Buy” from the nine ratings firms that are presently covering the firm, MarketBeat Ratings reports. Nine analysts have rated the stock with a buy rating. The average 12 month price target among brokerages that have updated their coverage on the stock […]
Needham & Company LLC Reiterates "Buy" Rating for Xenon Pharmaceuticals (NASDAQ:XENE) dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Xenon Pharmaceuticals (NASDAQ:XENE) PT Lowered to $60.00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Citigroup Lowers Xenon Pharmaceuticals (NASDAQ:XENE) Price Target to $60.00 tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Citigroup Lowers Xenon Pharmaceuticals (NASDAQ:XENE) Price Target to $60.00 dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.